Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
67
datasets available to search
ShareScore release 0.9.0
Dataset results
67 results for “cediranib”
Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers
ClinicalTrials.gov study NCT00939848. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS)
ClinicalTrials.gov study NCT01337401. IPD Sharing: Not stated. Countries: 3. Publications: 1.
An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer
ClinicalTrials.gov study NCT00532194. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT03117933. IPD Sharing: NO. Countries: 1. Publications: 2.
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
ClinicalTrials.gov study NCT00662506. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients
ClinicalTrials.gov study NCT03278717. IPD Sharing: NO. Countries: 4. Publications: 2.
Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00245154. IPD Sharing: NO. Countries: 6. Publications: 2.
Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies
ClinicalTrials.gov study NCT01364051. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours
ClinicalTrials.gov study NCT00621725. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple
ClinicalTrials.gov study NCT02484404. IPD Sharing: YES. Countries: 1. Publications: 3.
Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer
ClinicalTrials.gov study NCT02899728. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
ClinicalTrials.gov study NCT01062425. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
ClinicalTrials.gov study NCT00588900. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
ClinicalTrials.gov study NCT02498613. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
ClinicalTrials.gov study NCT01132820. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00475150. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer
ClinicalTrials.gov study NCT01208051. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers
ClinicalTrials.gov study NCT01229111. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)
ClinicalTrials.gov study NCT00306891. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma
ClinicalTrials.gov study NCT02974621. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.